A Study of NP001 in Subjects With Amyotrophic Lateral Sclerosis (ALS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01281631
Recruitment Status : Completed
First Posted : January 24, 2011
Last Update Posted : November 22, 2012
Information provided by (Responsible Party):
Neuraltus Pharmaceuticals, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Primary Completion Date : September 2012
  Study Completion Date : September 2012
  Certification/Extension First Submitted : November 20, 2012